Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[New molecules].

J Sternon1

  • 1Hôpital Erasme et C.U.M.G.-U.L.B.

Journal De Pharmacie De Belgique
|January 5, 2002
PubMed
Summary
This summary is machine-generated.

This study evaluates six medications, including clopidogrel and repaglinide, and the pneumococcal conjugate vaccine. It presents pros, cons, and expert opinions for each, aiding informed medical decisions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Traitement Des Infections Bronchopulmonaires Aigues Par Le Laurylsulfate De Tetracycline Intra-Musculaire.

Acta clinica Belgica·2016
Same author

[Varenicline: an aid to smoking cessation therapy].

Revue medicale de Bruxelles·2008
Same author

[Inhaled human insulin (Exubera): a revolution?].

Revue medicale de Bruxelles·2007
Same author

[Combination of Zocor with Ezetrol].

Revue medicale de Bruxelles·2007
Same author

[The war on generic drugs].

Revue medicale de Bruxelles·2006
Same author

[Pregabalin (Lyrica) and neuropathic pain syndromes].

Revue medicale de Bruxelles·2006
Same journal

[Evaluation of preoperative nutritional status in visceral surgery Correlational study].

Journal de pharmacie de Belgique·2018
Same journal

[Biosimilars, no generic biologicals!].

Journal de pharmacie de Belgique·2018
Same journal

[Drug-drug interactions with risk of QT-prolongation. A epidemiological study in Belgian community pharmacies].

Journal de pharmacie de Belgique·2018
Same journal

[Medication screening by the community pharmacist in Belgium].

Journal de pharmacie de Belgique·2018
Same journal

[Frequency and nature of drug related problems with corticosteroids in Belgian community pharmacies].

Journal de pharmacie de Belgique·2018
Same journal

[A practical program for outpatient parenteral antimicrobial therapy].

Journal de pharmacie de Belgique·2018
See all related articles

Area of Science:

  • Pharmacology and Therapeutics
  • Vaccinology
  • Drug Evaluation

Background:

  • Informed clinical decision-making requires a balanced understanding of pharmaceutical and biological agents.
  • Evaluating new and existing medical interventions is crucial for optimizing patient outcomes and healthcare resource allocation.

Purpose of the Study:

  • To provide a comprehensive overview of six specific medical interventions: clopidogrel, raloxifene, mecillinam, natiglinide, repaglinide, and the pneumococcal conjugate vaccine.
  • To critically assess the positive and negative aspects associated with each agent.
  • To identify and discuss unresolved questions and provide expert ratings for each intervention.

Main Methods:

  • Systematic review and critical appraisal of existing literature for each drug and vaccine.

Related Experiment Videos

  • Expert panel discussions and consensus-building on the merits and drawbacks.
  • Development of a structured rating system based on efficacy, safety, and clinical utility.

    • Main Results:

    • Detailed presentation of the benefits and risks for clopidogrel, raloxifene, mecillinam, natiglinide, repaglinide, and the pneumococcal conjugate vaccine.
    • Identification of key areas requiring further research or clinical clarification for each evaluated agent.
    • Provision of expert-derived ratings reflecting the overall assessment of each intervention.

    Conclusions:

    • The study offers a structured evaluation framework for medical interventions, highlighting the importance of evidence-based assessment.
    • Findings provide valuable insights for clinicians, researchers, and policymakers regarding the use of clopidogrel, raloxifene, mecillinam, natiglinide, repaglinide, and pneumococcal conjugate vaccine.
    • The presented ratings and unresolved questions serve as a guide for future research and clinical practice.